Zacks Research Has Bullish Estimate for MD FY2025 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Zacks Research upped their FY2025 earnings per share estimates for shares of Pediatrix Medical Group in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings per share of $1.39 for the year, up from their previous estimate of $1.20. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group's FY2026 earnings at $1.43 EPS.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%.

Other research analysts have also issued reports about the stock. Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective on the stock. Truist Financial raised their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. UBS Group raised their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Finally, Mizuho lifted their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $17.08.

Remove Ads

Pediatrix Medical Group Stock Performance

Shares of MD traded down $0.08 during mid-day trading on Monday, reaching $13.85. 351,919 shares of the company's stock were exchanged, compared to its average volume of 814,390. The business's fifty day simple moving average is $14.13 and its 200-day simple moving average is $13.38. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The stock has a market capitalization of $1.19 billion, a PE ratio of -11.51, a price-to-earnings-growth ratio of 1.74 and a beta of 1.48. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Nomura Asset Management Co. Ltd. grew its holdings in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares during the period. Quest Partners LLC boosted its position in Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after purchasing an additional 622 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP increased its position in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after buying an additional 1,662 shares in the last quarter. Finally, AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.